We are live on ! Find out more
2

2Xideas Portfolio holdings

AUM $255M
1-Year Est. Return 0.46%
This Fund
S&P 500
This Quarter Est. Return
-18.05%
1 Year Est. Return
+0.46%
3 Year Est. Return
+33.96%
5 Year Est. Return
+43.71%
10 Year Est. Return
AUM
$1.09B
AUM Growth
-$323M
Cap. Flow
-$52.6M
Cap. Flow %
-4.81%
Top 10 Hldgs %
42.26%
Holding
77
New
3
Increased
27
Reduced
43
Closed
4

Top Buys

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$14M
2
ADI icon
Analog Devices
ADI
+$12.4M
3
WD icon
Walker & Dunlop
WD
+$11.5M
4
MASI
Masimo
MASI
+$4.6M
5
STNE icon
StoneCo
STNE
+$4.3M

Sector Composition

Rank Sector Weight
1 Healthcare 28.66%
2 Technology 25.24%
3 Financials 18.1%
4 Industrials 9.17%
5 Consumer Discretionary 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTD icon
76
Mettler-Toledo International
MTD
$26.8B
-9,416
Closed -$12.9M
TRUP icon
77
Trupanion
TRUP
$1.05B
-21,117
Closed -$1.88M

Similar funds

2Xideas's Q2 2022 Portfolio in Review

As of Q2 2022, 2Xideas held 77 positions worth $1.09B, down 23% from $1.42B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

2Xideas withdrew a net $52.6M in Q2 2022, closing 4 positions and reducing 43 holdings. Its most notable exit was Factset, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, 2Xideas opened a new position in Halozyme worth $14.3M.

  • 2Xideas's largest Q2 2022 buy was Halozyme: 324,619 shares worth $14.3M.
  • 2Xideas added most to Masimo in Q2 2022, an estimated $4.6M increase.
  • 2Xideas's biggest Q2 2022 reduction was Intercontinental Exchange, cutting an estimated $8.22M.
  • 2Xideas fully exited Factset in Q2 2022, selling an estimated $14.1M.
  • 2Xideas's ten largest holdings make up 42% of its $1.09B portfolio in Q2 2022.
  • 2Xideas opened 3 new positions and closed 4 in Q2 2022.
  • 2Xideas's portfolio value fell 23% quarter-over-quarter to $1.09B.

Based on 2Xideas's 13F filing for Q2 2022, filed 15 Aug 2022.